79352-66-2 Usage
Description
4-(Benzyloxy)-2-bromophenol is an organic compound characterized by the presence of a benzyloxy group attached to the 4-position and a bromine atom at the 2-position of a phenol molecule. This unique structure endows it with specific chemical properties that make it a valuable intermediate in the synthesis of various pharmaceutical compounds.
Uses
Used in Pharmaceutical Synthesis:
4-(Benzyloxy)-2-bromophenol is used as an intermediate in the synthesis of (S)-4-Hydroxy Penbutolol Hydrochloride (H948945), a hydroxylated metabolite of Penbutolol (P220500). This intermediate plays a crucial role in the production of pharmaceuticals, contributing to the development of medications with potential therapeutic benefits.
Check Digit Verification of cas no
The CAS Registry Mumber 79352-66-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,9,3,5 and 2 respectively; the second part has 2 digits, 6 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 79352-66:
(7*7)+(6*9)+(5*3)+(4*5)+(3*2)+(2*6)+(1*6)=162
162 % 10 = 2
So 79352-66-2 is a valid CAS Registry Number.
79352-66-2Relevant articles and documents
Synthesis of novel 2H-spiro[1-benzofuran-3,4′-piperidin]ol scaffolds
Leflemme, Nicolas,Stoit, Axel R.,Borghese, Alfio
experimental part, p. 2432 - 2435 (2012/06/01)
With the aim to enrich our 'privileged structure'-based library, novel 2H-spiro[1-benzofuran-3,4′-piperidin]ol scaffolds were prepared. The method involved a key intramolecular Heck cyclization which was successfully applied for three series of compounds.
COMPOUNDS AND COMPOSITIONS AS PPAR MODULATORS
-
Page/Page column 57, (2008/06/13)
The invention provides compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with the activity of the Peroxisome Proliferator-Activated Receptor (PPAR) families.
Novel imidazotriazinones and the use thereof
-
, (2008/06/13)
Novel imidazotrizinones of general formula (I), a method for the production and the pharmaceutical use thereof are disclosed.